Chemical Compound
2-Desisopropyl-2-ethyl Ritonavir
CAS Registry Number
165315-26-4
Primary Record
2-Desisopropyl-2-ethyl Ritonavir
Note: Only for scientific research or as raw materials for production.
- In stock
- 6,864 g
- Purity
- 99.5 %
- CAS
- 165315-26-4
Compound Identifiers & Properties
- CAS
- 165315-26-4
- PubChem CID
- 482956
- SMILES
- CCC1=NC(=CS1)CN(C)C(=O)N[C@@H](C(C)C)C(=O)N[C@@H](CC2=CC=CC=C2)C[C@@H]([C@H](CC3=CC=CC=C3)NC(=O)OCC4=CN=CS4)O
- Canonical SMILES
- CCc1nc(CN(C)C(=O)N[C@H](C(=O)N[C@@H](Cc2ccccc2)C[C@H](O)[C@H](Cc2ccccc2)NC(=O)OCc2cncs2)C(C)C)cs1
Names & Synonyms
- 2-Desisopropyl-2-ethyl Ritonavir
- Ritonavir EP Impurity I
- UNII-6M6X3D822N
- 165315-26-4
- RefChem:86768
- AC1LA7KO
- Ritonavir USP Impurity F
- 6M6X3D822N
- DTXSID60167921
- AC1Q66D6
- SCHEMBL7091129
- DTXCID5090412
- AIDS104344
- AR-1K5121
- CID482956
- ZINC27657821
- RITONAVIR IMPURITY I [EP IMPURITY]
- RITONAVIR IMPURITY I (EP IMPURITY)
- J924.092F
- 1,3-thiazol-5-ylmethyl N-[(2S,3S,5S)-5-[[(2S)-2-[[(2-ethyl-1,3-thiazol-4-yl)methyl-methylcarbamoyl]amino]-3-methylbutanoyl]amino]-3-hydroxy-1,6-diphenylhexan-2-yl]carbamate
- [5S-(5R*,8R*,10R*,11R*
- Q27265143
- 2,4,7,12-Tetraazatridecan-13-oic acid, 1-(2-ethyl-4-thiazolyl)-10-hydroxy-2-methyl-5-(1-methylethyl)-3,6-dioxo-8,11-bis(phenylmethyl)-, 5-thiazolylmethyl ester, (5S-(5R*,8R*,10R*,11R*))-
- RITONAVIR IMPURITY, ETHYL ANALOG- [USP IMPURITY]
- RITONAVIR IMPURITY, ETHYL ANALOG-(USP IMPURITY)
- RITONAVIR IMPURITY, ETHYL ANALOG-[USP IMPURITY]
- Thiazol-5-ylmethyl ((2S,3S,5S)-5-((S)-2-(3-((2-ethylthiazol-4-yl)methyl)-3-methylureido)-3-methylbutanamido)-3-hydroxy-1,6-diphenylhexan-2-yl)carbamate
- 2,4,7,12-TETRAAZATRIDECAN-13-OIC ACID, 1-(2-ETHYL-4-THIAZOLYL)-10-HYDROXY-2-METHYL-5-(1-METHYLETHYL)-3,6-DIOXO-8,11-BIS(PHENYLMETHYL)-, 5-THIAZOLYLMETHYL ESTER, (5S,8S,10S,11S)-
- n2-{[(2-ethyl-1,3-thiazol-4-yl)methyl](methyl)carbamoyl}-n-[(2s,4s,5s)-4-hydroxy-1,6-diphenyl-5-{[(1,3-thiazol-5-ylmethoxy)carbonyl]amino}hexan-2-yl]-l-valinamide
- THIAZOL-5-YLMETHYL (((1S,2S,4S)-1-BENZYL-4-(((2S)-2-((((2-ETHYLTHIAZOL-4-YL)METHYL)METHYLCARBAMOYL)AMINO)-3-METHYLBUTANOYL)AMINO)-2-HYDROXY-5-PHENYLPENTYL)CARBAMATE
- (1,3-thiazol-5-yl)methyl N-[(2S,3S,5S)-5-[(2S)-2-({[(2-ethyl-1,3-thiazol-4-yl)methyl](methyl)carbamoyl}amino)-3-methylbutanamido]-3-hydroxy-1,6-diphenylhexan-2-yl]carbamate
- (5S,8S,10S,11S)-1-(2-Ethyl-4-thiazolyl)-10-hydroxy-2-methyl-5-(1-methylethyl)-3,6-dioxo-8,11-bis(phenylmethyl)-2,4,7,12-tetraazatridecan-13-oic Acid 5-Thiazolylmethyl Ester
- [5S-(5R*,8R*,10R*,11R*)]-1-(2-Ethyl-4-thiazolyl)-10-hydroxy-2-methyl-5-(1-methylethyl)-3,6-dioxo-8,11-bis(phenylmethyl)-2,4,7,12-tetraazatridecan-13-oic Acid 5-Thiazolylmethyl Ester
- 1,3-thiazol-5-ylmethyl N-((2S,3S,5S)-5-(((2S)-2-(((2-ethyl-1,3-thiazol-4-yl)methyl-methylcarbamoyl)amino)-3-methylbutanoyl)amino)-3-hydroxy-1,6-diphenylhexan-2-yl)carbamate
- 2,4,7,12-Tetraazatridecan-13-oic acid, 1-(2-ethyl-4-thiazolyl)-10-hydroxy-2-methyl-5-(1-methylethyl)-3,6-dioxo-8,11-bis(phenylmethyl)-, 5-thiazolylmethyl ester, (5S,8S,10S,11S)- ; 2,4,7,12-Tetraazatridecan-13-oic acid, 1-(2-ethyl-4-thiazolyl)-10-hydroxy-2-methyl-5-(1-methylethyl)-3,6-dioxo-8,11-bis(phenylmethyl)-, 5-thiazolylmethyl ester, [5S-(5R*,8R*,10R*,11R*)]-; Ritonavir Imp. I (EP)
- 2,4,7,12-Tetraazatridecan-13-oic acid, 1-(2-ethyl-4-thiazolyl)-10-hydroxy-2-methyl-5-(1-methylethyl)-3,6-dioxo-8,11-bis(phenylmethyl)-, 5-thiazolylmethyl ester, [5S-(5R*,8R*,10R*,11R*)]-
- 30777-81-2
- N-[(1S,2S,4S)-1-Benzyl-2-hydroxy-4-[[[[methyl[(2-ethyl-4-thiazolyl)methyl]amino]carbonyl]-L-valyl]amino]-5-phenylpentyl]carbamic acid 5-thiazolylmethyl ester
- N~2~-{[(2-Ethyl-1,3-thiazol-4-yl)methyl](methyl)carbamoyl}-N-[(2S,4S,5S)-4-hydroxy-1,6-diphenyl-5-({[(1,3-thiazol-5-yl)methoxy]carbonyl}amino)hexan-2-yl]-L-valinamide
- thiazol-5-ylmethyl N-[(1S,2S,4S)-1-benzyl-4-[[(2S)-2-[[(2-ethylthiazol-4-yl)methyl-methyl-carbamoyl]amino]-3-methyl-butanoyl]amino]-2-hydroxy-5-phenyl-pentyl]carbamate